A dendritic cell vaccine was safe and induced immune responses in patients with multiple myeloma

A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma.
Read More